Sodium hydride → HCID 58408389, compound
Reaction equation
[H-].[Na+].[CH3:3][C:4]1([CH2:8][OH:9])[CH2:7][O:6][CH2:5]1.[CH:10]([CH:13]1[C:18]2[N:19]=[CH:20][NH:21][C:17]=2[CH2:16][CH2:15][N:14]1[C:22](OCC(Cl)(Cl)Cl)=[O:23])([CH3:12])[CH3:11]>C1COCC1>[CH:10]([CH:13]1[C:18]2[N:19]=[CH:20][NH:21][C:17]=2[CH2:16][CH2:15][N:14]1[C:22]([O:9][CH2:8][C:4]1([CH3:3])[CH2:7][O:6][CH2:5]1)=[O:23])([CH3:12])[CH3:11]Participants
Conditions
- Temperature
- 0 °C
Procedure
NaH (0.19 g, 4.80 mmol, 60% dispersion in mineral oil) was suspended in anhydrous THF (10 mL), cooled to 0° C. and 3-methyl-3-oxetane methanol (0.41 g, 4.00 mmol) was added. The suspension was stirred at 0° C. for 30 min then added to a solution of Intermediate 2 (1.33 g, 4.00 mmol, 70% pure) in THF (10 mL) and the reaction mixture was stirred at room temperature. Two additional such portions of NaH and 3-methyl-3-oxetane methanol in THF were added after 8 and 32 h, respectively. After 50 h the reaction mixture was quenched with water (10 mL) and the solvents were removed in vacuo. The residue was dissolved in EtOAc (100 mL) washed with 1 M aq Na2CO3 solution (4×100 mL), dried (MgSO4) and the solvents were removed in vacuo. The residue was purified by column chromatography (normal phase, 20 g, Strata SI-1, silica gigatube, DCM (200 mL) followed by 2%, 4%, 5%, 10% and 20% MeOH in DCM (200 mL each)) and by reverse phase HPLC (YMC ODS-A 100×20 mm, 5 μm, 25 mL/min, gradient 20% to 100% (over 7 min) then 100% (3 min) MeOH in 10% MeOH/water) to give (3-methyloxetan-3-yl)methyl 4-isopropyl-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridine-5-carboxylate (68.2 mg, 5.8%) as a white solid.
Workup
- stirringthe reaction mixture was stirred at room temperature
- customAfter 50 h the reaction mixture was quenched with water (10 mL)
- customthe solvents were removed in vacuo
- dissolutionThe residue was dissolved in EtOAc (100 mL)
- washwashed with 1 M aq Na2CO3 solution (4×100 mL)
- dry with materialdried (MgSO4)
- customthe solvents were removed in vacuo
- customThe residue was purified by column chromatography (normal phase, 20 g, Strata SI-1, silica gigatube, DCM (200 mL) followed by 2%, 4%, 5%, 10% and 20% MeOH in DCM (200 mL each)) and by reverse phase HPLC (YMC ODS-A 100×20 mm, 5 μm, 25 mL/min, gradient 20% to 100% (over 7 min)
Sources & evidence
- ORD record
- ord-0c39efa76e3f40f891787781ac84217c
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08263616B2
Reaction notes
Loading…